Evaluation of the safety and immunogenicity of subcutaneous HX575 epoetin alfa in the treatment of anemia associated with chronic kidney disease in predialysis and dialysis patients

Aim: To assess the safety and immunogenicity of subcutaneous (SC) HX575 (epoetin-α) in dialysis- and nondialysis-dependent adult patients with chronic kidney disease (CKD). Methods: Open-label, single-arm, multicenter study in patients (n = 416) from Germany, Italy, Poland, Romania, Russia, Turkey,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Nephrol
Asıl Yazarlar: Casadevall, Nicole, Dobronravov, Vladimir, Eckardt, Kai-Uwe, Ertürk, Sehsuvar, Martynyuk, Liliya, Schmitt, Susanne, Schaffar, Gregor, Rudy, Anita, Krendyukov, Andriy, Ode, Marité
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dustri-Verlag Dr. Karl Feistle 2017
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5607454/
https://ncbi.nlm.nih.gov/pubmed/28766493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/CN109159
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller